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13 Abstract
14 Rationale Recent evidence suggests that in addition to con-
15 trolling emotional behavior in general, endocannabinoid sig-
16 naling is engaged in shaping behavioral responses to chal-
17 lenges. This important function of endocannabinoids is still
18 poorly understood.
19 Objectives Here we investigated the impact of blockade of
20 fatty acid amide hydrolase (FAAH), the degrading enzyme of
21 anandamide on behavioral responses induced by challenges of
22 different intensity.
23 Methods Mice treated with FAAH inhibitor URB597 were
24 either manually restrained on their backs (back test) or received
25 foot-shocks.
26 Results The behavior of mice showed bimodal distribution in
27 the back test: they either predominantly showed escape at-
28 tempts or equally distributed time between passivity and es-
29 cape. URB597 increased escapes in animals with low escape
30 scores. No effects were noticed in mice showing high escape
31 scores, which is likely due to a ceiling effect. We hypothesized
32 that stronger stressors would wash out individual differences
33 in coping; therefore, we exposed mice to foot-shocks that
34 decreased locomotion and increased freezing in all mice.
35 URB597 ameliorated both responses. The re-exposure ofmice
36 to the shock cage 14 days later without delivering shocks or
37 treatment was followed by reduced and fragmented sleep as
38 shown by electrophysiological recordings. Surprisingly, sleep
39 was more disturbed after the reminder than after shocks in rats
40 receiving vehicle before foot-shocks. These reminder-induced
41 disturbances were abolished by URB597 administered before
42 shocks.
43Conclusions These findings suggest that FAAH blockade has
44an important role in the selection of behavioral responses
45under challenging conditions and—judging from its long-
46term effects—that it influences the cognitive appraisal of the
47challenge.
48Keywords Back test . Conditioned fear . Coping . FAAH .
49Inescapable foot shock .Mouse . URB597
50Introduction
51Active coping is a therapeutic goal in a variety of physical and
52mental diseases (Cooke et al. 2007; Westerhuis et al. 2011). A
53growing body of evidence suggests that the endocannabinoid
54system—in addition to its effects on anxiety-like and
55depression-like behavior—affects the way animals cope with
56challenges. Early work with knockout animals already
57showed that the effects of cannabinoid type-1 receptor
58(CB1) gene disruption depend on environmental conditions
59in the elevated plus-maze (Haller et al. 2004). Particularly, the
60behavior of CB1 knock-out (CB1 KO) and wild-type mice
61was similar under low light—i.e., less aversive conditions—
62but CB1 gene disruption increased anxiety-like behavior un-
63der the more aversive high light condition. Thus, the
64anxiogenic-like effect of CB1 gene disruption was restricted
65to the more stressful unfamiliar environment, suggesting that
66disrupted endocannabinoid signaling exacerbates anxiety un-
67der challenging conditions.
68Recent work with the fatty acid amide hydrolase (FAAH)
69inhibitor URB597—which increases the brain availability of
70the endocannabinoid anandamide—supports the notion that
71the effects of endocannabinoids depend on environmental
72conditions; particularly, behavioral effects become more
73prominent under conditions of environmental aversiveness.
74The first indication came from a study by Naidu et al.
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75 (2007), who showed that the compound decreased depression-
76 and anxiety-like behaviors under specific conditions only,
77 more precisely under conditions that have been perceived as
78 stressful for subjects. By studying the issue further, Haller
79 et al. (2009) showed that FAAH inhibition by URB597 de-
80 creases anxiety by blunting the behavioral impact of aversive
81 conditions; the aversiveness of the testing environment was
82 evidenced by glucocorticoid measurements in this study.
83 Similar findings were obtained with the monoacylglycerol
84 lipase inhibitor JZL184 that enhances signaling by 2-
85 arachidonoylglycerol and another endogenous CB1 agonist
86 by inhibiting its hydrolyzing enzyme (Aliczki et al. 2012;
87 Sciolino et al. 2011). These findings suggest that in contrast
88 to CB1 gene disruption that exacerbates behavioral responses
89 to challenging conditions, increased endocannabinoid signal-
90 ing dampens the effects of such challenging conditions. In a
91 recent study, McLaughlin et al. (2012) showed that URB597
92 promotes active coping in the forced swimming test, which
93 also supports the notion that endocannabinoids are involved in
94 coping with environmental challenges.
95 To further assess the role of endocannabinoid signaling in
96 challenge responding, we studied here the effects of the FAAH
97 inhibitor URB597 in the back test where subjects are manually
98 restrained on their backs for 1 min, and escape attempts from
99 this forced unnatural position are considered as active coping
100 responses (Hawley et al. 2010; Lambert et al. 2006; Ruis et al.
101 2001). The compound increased escape attempts in subjects
102 that showed low, but not in those showing high, escape scores
103 at baseline. To control for this putative ceiling effect, a different
104 set of mice was exposed to unavoidable foot-shocks that result
105 in freezing, i.e., in passive challenge responding in all
106 undrugged mice. We hypothesized that URB597 would dimin-
107 ish inactivity induced by shocks in all mice, i.e., it would
108 promote active coping with the challenge. Based on earlier data
109 on the relationship between active coping and resilience under
110 adverse conditions (Koolhaas et al. 1999,Q1 2007), we also hy-
111 pothesized that URB597 would reduce the long-term impact of
112 shocks on emotional responses triggered by contextual re-
113 minders. The reminder was administered to the same subjects
114 14 days later and performed without the administration of foot-
115 shocks or pharmacological treatments. Emotional responses
116 were evaluated by freezing responses shown during and sleep
117 patterns shown after the contextual reminder.
118 Materials and methods
119 Subjects
120 Subjects were 2–3-month-old male CD1 mice (Charles River
121 Laboratories; Hungary) weighing approximately 30 g. Food
122 and water were available ad libitum; temperature and relative
123 humidity were kept at 22±2 °C and 60±10 %, respectively.
124Mice were maintained in a normal light cycle of 12 h with lights
125on at 07:00 h. In contrast to rats that are highly social, individual
126housing is not stressful in the mouse, which is a solitary species
127(Arndt et al. 2009; Benton andBrain 1981; Capanna et al. 1984).
128Moreover, mice establish strong dominance hierarchies
129(Capanna et al. 1984; Poshivalov 1980), which would have
130constituted a confounding factor in this experimental design if
131the mice were housed in groups. Therefore, all mice were
132housed individually for 2 weeks before experimentation. Mice
133were experimentally naïve with no drug history prior to the
134experiment and used in one experiment only.
135Experiments were carried out in accordance with the
136European Communities Council Directive of 24 November
1371986 (86/609/EEC) and were reviewed and approved by the
138Animal Welfare Committee of our Institute.
139Drugs and doses
140URB597 (Sigma, Budapest, Hungary) was dissolved in 0.2 ml
141dimethylsulfoxide, which was diluted to a final volume with
142saline that contained 0.4 % methylcellulose, a biologically
143neutral solvent, and was injected intraperitoneally at a dose
144of 0.3 mg/kg and a volume of 10 ml/kg 40 min before testing.
145At this time point, 0.3mg/kg URB597 has a maximal effect on
146brain anandamide, which is increased about threefold over
147basal levels (Kathuria et al. 2003; Piomelli et al. 2006).
148Behavioral testing
149All behavioral tests were conducted in the first 3 h of the light
150period in an experimental room at 400-lx light intensity.
151Behavior during testing was recorded with a Sony DCR-
152SR75 digital camcorder (Sony Electronics, San Diego, CA,
153USA). Later, behavioral recordings were analyzed with the
154H77 event recorder software (Jozsef Haller, Budapest,
155Hungary).
156Back test The back test was developed in piglets (Ruis et al.
1572001) and was later adapted to rats to evaluate coping with a
158challenging situation, e.g., a forced unnatural position
159(Hawley et al. 2010; Lambert et al. 2006). Subjects are man-
160ually restrained on their backs for 1 min, and escape attempts
161are considered indicative of active coping. This behavior
162shows a biphasic distribution: the behavior of subjects is either
163dominated by escape attempts or by more passive responses,
164e.g., resting. Consequently, subjects with values close to the
165group mean were less frequent than “extremes” (passive and
166active coping), i.e., overall averages describe behavior poorly
167in this test. Therefore, subjects are usually divided into active
168and passive copers, who are evaluated separately (Hawley et al.
1692010; Lambert et al. 2006; Koolhaas et al. 1999, 2007; Ruis
170et al. 2001). The behavior of the two phenotypes is rather
171consistent over time.We employed a repeated-measures design
Psychopharmacology
JrnlID 213_ArtID 3273_Proof# 1 - 04/09/2013
AUTHOR'S PROOF!
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
172 here to evaluate the impact of URB597 in conjunction with the
173 pre-existing phenotype of mice (see “Experimental design”).
174 As the test was not employed in mice so far, we performed a
175 preliminary study in 18 mice to identify the behaviors shown in
176 this test and to establish whether the test was repeatable without
177 major changes in behavior. Mice were exposed to the test three
178 times at 7-day intervals. We identified four distinct behaviors:
179 resting (no movements except for breathing and small head
180 movements), escape attempts (vigorous body and limb move-
181 ments aimed at escaping restraint), body twitches , and bites
182 directed towards the hand of the experimenter. Regarding bites,
183 we note that the experimenter wore thick gloves over the latex
184 examination gloves, which prevented pain and injuries from
185 bites; therefore, the manual restraint was consistent and had no
186 impact on the behavior of subjects. Twitches and bites were
187 very short (< 1 s); consequently, mice divided test time between
188 escape attempts and resting. Overall, time devoted to escape
189 was longer than that devoted to resting. Similar to piglets and
190 rats, individual differences were large and allowed the identifi-
191 cation of distinct coping styles based on escape/resting ratios
192 (see later discussion). The duration of resting and escape at-
193 tempts was consistent over time (Spearman correlation coeffi-
194 cients for behavior shown in the three trials were between 0.627
195 and 0.697, while p values were between 0.005 and 0.001). As
196 expected, a bimodal distribution of coping styles was seen in
197 this preliminary study; only 17.6% of subjects showed amixed
198 strategy; the rest were either more passive or more active. This
199 preliminary study showed that the behavior of mice is well
200 characterized by the duration of resting and escape attempts
201 and that the repeated-measures approach is applicable.
202 Unavoidable foot-shocks and the contextual reminder Un-
203 avoidable foot-shocks are dramatic stressors that—in contrast
204 to forcing mice on their backs—do not differentiate coping
205 styles because all subjects show a robust inhibition of behav-
206 ior throughout shock exposure. In addition, behavior is altered
207 in the long run by a single exposure—a phenomenon known
208 as conditioned fear—which per se precludes repeatability.
209 Therefore, foot-shocks were administered once, and the ef-
210 fects of URB597were evaluated in groups that were studied in
211 parallel. The test was employed to study the impact of this
212 compound on copingwith a severe stressor and to evaluate the
213 long-term consequences of both the shock per se and URB597
214 treatment administered before shocks.
215 Shocks were delivered and contextual reminders were ad-
216 ministered in a separate, quiet experimental room. On the first
217 day, mice were introduced into the Plexiglas box (30×30×
218 30 cm). Shocks were administered via the grid floor of the
219 box. Two shock trains of 1 s were administered per minute for
220 5 min (i.e., each mouse received ten shocks). Each shock train
221 (100 V, 3 mA) was 1 s in length and consisted of 0.01-s shocks
222 separated by 0.02-s-long breaks. The box was cleaned with
223 ethanol between each subject.
224Behavior was recorded by a video camera placed 1.5 m
225above the Plexiglas box. For behavioral scoring, the box
226where mice received shocks was covered by a 10×10-cm grid
227on the video screen. Locomotion was evaluated by counting
228the lines crossed by animals by all four paws. Runs prompted
229by shocks per se and locomotion between shocks was counted
230separately. Exploration directed in the air or the walls (upward
231search) and those directed below the metallic grid (downward
232search) were counted separately as well. Freezing (complete
233immobility, no movements of the snout) was also scored.
234
235Surgery and EEG/EMG recordings
236We instrumented the subjects with EEG and EMG electrodes
237as described previously (Kantor et al. 2009). Briefly, under
238anesthesia with ketamine–xylazine (100 and 10 mg/kg ip),
239stainless steel screw electrodes were implanted epidurally
240over the left frontal cortex (1.5 mm lateral and 1 mm anterior
241to Bregma) and left parietal cortex (1.5 mm lateral and 1.0 mm
242anterior to Lambda) for fronto-parietal EEG recordings. The
243ground electrode was placed over the cerebellum. EMG sig-
244nals were acquired by a pair of stainless steel spring wires
245(Plastics One Inc., Roanoke, VA, USA) inserted into the neck
246extensor muscles.
247The recording cable was attached to a low torque commu-
248tator, fixed above the cages that allowed free movement. The
249EEG/EMG signals were acquired using MultiAmp amplifiers
250(Supertech Ltd., Pecs, Hungary), analog band pass-filtered at
2510.53–80 Hz, and digitized at 256 Hz using a sleep scoring
252system (SleepSign, Kissei Comtec, Matsumoto, Japan). The
253signals were then digitally filtered (EEG, 0.5–60Hz; EMG, 5–
25460 Hz) and semiautomatically scored in 10-s epochs. K.S. and
255S.K. visually inspected all scoring and made corrections when
256appropriate. To examine the changes in sleep architecture of
257shock-trained mice, sleep amount was recorded and calculated
258every 30 min in the first 210 min that followed the shock or
259the contextual reminder. Sleep amount was expressed as % of
260these 30-min-long periods. The number of awakenings was
261also counted and was expressed as the number of awakenings
262per minute of sleep. This variable was referred to as sleep
263fragmentation.
264Experimental design
265In experiment 1, we studied the effects of URB597 on coping
266styles in the back test. Mice were tested three times at 7-day
267intervals after treatments that were administered 40 min prior
268to testing (N =40). The first trial preceded by vehicle injec-
269tions was considered habituation to treatment and testing
270procedure. The coping style of mice was established based
271on behavior shown during the second trial. All mice received
272vehicle before this trial. Overall, the duration of escape
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273 attempts was larger than the duration of resting, confirming that
274 the stressor was mild and did not induce a general inhibition of
275 behavior.Micewere categorized as passive copers if the escape/
276 resting ratio was smaller than 1.5. In these mice, the duration of
277 escape attempts was larger than the duration of resting by 33 %
278 or less. Mice were assigned to the active coping group if the
279 escape/resting ratio was larger than 3. In these mice, the dura-
280 tion of escape attempts was larger than the duration of resting
281 by 66 % or more. Mice showing intermediate scores were
282 considered mixed copers. Mice were treated either with
283 URB597 or with saline before the third trial. Assignment was
284 based on behavior shown in the second trial to ensure similar
285 shares of coping styles within treatment groups.
286 In experiment 2, we studied the behavioral and emotional
287 responses elicited by unavoidable foot-shocks and a contex-
288 tual reminder administered 14 days later. Mice were instru-
289 mented with EEG and EMG electrodes as described in
290 “Surgery and EEG/EMG recordings” and were allowed
291 1 week to recover. They were habituated to the cables for 4–
292 5 days before the experiments. On the day when shocks were
293 administered, mice were connected to the recording cables at
294 7 AM. Baseline values for sleep patterns were obtained be-
295 tween 8 and 9 AM. At 20 min later, mice were treated with
296 vehicle or URB597, and after another 40 min they were
297 disconnected from the recording cables and were transferred
298 to a quiet room (separated from the housing room) where foot-
299 shocks were delivered. Behavior shown during shock expo-
300 sure was video-recorded and analyzed later by an exper-
301 imenter blind to treatments. Recordings were restarted in
302 the home-cage immediately after shock delivery and lasted
303 210 min.
304 The contextual reminder was administered 14 days after
305 shock exposure. As during the shock day, mice were
306 connected to the recording cables at 7 AM, and baseline sleep
307 patterns were established between 8 and 9 AM. Mice were
308 transferred to the shock-associated Plexiglas boxes at 10 AM.
309 Neither pharmacological treatment nor shocks were adminis-
310 tered. Behavior shown in the shock-associated environment
311 was video-recorded and was later analyzed by an experiment-
312 er blind to the treatments. Note that treatments were adminis-
313 tered 14 days earlier during shock exposure. Freezing—a
314 typical conditioned fear-related behavior—was scored. EEG
315 recordings were resumed in the home-cage immediately after
316 the contextual reminder and lasted 210 min.
317 Statistical analyses
318 The back test Correlations were estimated by linear regression
319 (predictor variable: behavior during trial 2; dependent vari-
320 able: behavior during trial 3). Behavioral differences were
321 evaluated by three-factor ANOVA (factor 1: treatment; factor
322 2: coping style; repeated-measures factor 3: trial). As the
323 interaction between these three factors was significant,
324separate two-factor ANOVAs were run for the treatment
325groups (factor 1: coping; factor 2: trial).
326Foot-shocks and reminder Behaviors typical to shock expo-
327sure (e.g., “shock-runs” and behaviors shown between shock
328presentations) were evaluated by two-factor ANOVA (factor 1:
329treatment; repeated-measures factor 2: time, i.e., the sequential
330number of shocks or pauses between shocks). Sleep patterns
331were compared by two-factor ANOVA. Factor 1 was the ex-
332perimental condition that had four levels: (1) vehicle-treated
333before shock, measured after shock; (2) vehicle-treated before
334shock, measured after reminder; (3) URB597-treated before
335shock, measured after shock; and (4) URB597-treated before
336shock, measured after reminder. Post-shock and post-reminder
337measurements were made in the same animals. Repeated-
338measures factor 2 was the time elapsed from shock or reminder.
339Where the main effect was significant, post-hoc Fisher's LSD
340tests were performed for pair-wise comparisons. Significance
341level was set at p<0.05. P values underwent Bonferoni correc-
342tion for multiple comparisons (Holm's procedure).
343
344Results
345The effects of URB597 on escape attempts in the back test
346As the duration of resting and escape attempts was mutually
347exclusive (the other two behaviors being very short; see earlier
348discussion), only data on escape attempts were shown here.
349URB597 did not affect the duration of escape attempts overall.
350However, the correlation between behaviors shown in trials 2
351and 3 showed interesting differences between the treatment
352groups. The correlation between the two trials was significant
353in mice treated with vehicle before both trials (R =0.479; p =
3540.03) (Fig. 1a). These findings replicated those obtained in the
355preliminary study (see “Materials and methods”). There was no
356correlation between behaviors shown in the two trials when trial
3573 was preceded by URB597 injections (R =0.128; p =0.59)
358(Fig. 1b). Particularly, mice showing low escape scores after
359vehicle spent considerably more time with escape attempts after
360URB597. The most active animals showed escape attempts for
361most of the time; as such, the duration of this behavior was
362likely unable to show further increases due to a ceiling effect.
363To control for the impact of baseline behavior, data were
364reanalyzed by taking coping styles into account. These were
365delimited as described in “Materials and methods”. Coping
366styles showed a bimodal distribution as expected based on
367earlier findings. Only 26.3 % of subjects showed a mixed
368strategy; the rest adopted either more passive (39.5 %) or more
369active coping (34.2 %). The behavior of mice was determined
370by an interaction between treatment (factor 1), coping (factor 2),
371and trial (repeated-measures factor 3) (Wilk's lambda=0.174;
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372 F interaction(4, 66)=22.97; p <0.0001). In a second analysis (per-
373 mitted by the significant interaction between the three factors),
374 we investigated behavioral changes within treatment groups. In
375 subjects treated with vehicle before both trials, behavior was
376 affected by coping styles but not by the trial (Fcoping(2, 32)=
377 9.41, p =0.0006; F trial(1, 32)=0.75, p =0.39; F interaction(2, 32)=
378 0.66, p =0.52). The duration of escape attempts was similar in
379 the two trials for all three coping styles (p >0.5) (Fig. 1c). In
380 contrast, in mice treated with URB597 before trial 3, behavior
381 was defined by an interaction between coping and trial
382 (F interaction (2, 32)=8.63, p =0.001). Particularly, mice that
383 adopted a passive style in the vehicle trial shifted towards a
384 more active style after URB597 (p =0.02) (Fig. 1d). No similar
385 changes were seen in mice adopting mixed or active styles in
386 trial 2. In addition, the passive/active difference evident after
387 vehicle (p =0.0001) disappeared after URB597 (p =0.9).
388 Taken together, these findings suggest that URB597 pro-
389 moted an active coping style in mice that showed passive
390 coping at baseline. One can hypothesize that a similar
391 change was prevented in the other two coping groups by a
392 ceiling effect.
393Behavioral responses to unavoidable foot-shocks
394In experiment 2, each shock elicited runs of about 50 cm (five
395line crossings) that were not affected by URB597 treatment
396(F treatment (1, 12)=0.15; p<0.2) (Fig. 2a). This suggests that
397pain sensitivity was not affected by URB597. However, FAAH
398inhibition significantly affected the behavior observed between
399shock presentations. Locomotion shown during the 30-s breaks
400that separated shocks was gradually reduced from about 10 cm
401to almost nil in vehicle-treated mice, but not in mice treated with
402the FAAH inhibitor. There were two waves of locomotion bouts
403in URB597-treated mice, resulting in an overall increase in
404locomotion (F treatment (1, 12)=7.07; p<0.03) (Fig. 2b). In par-
405allel with this change, freezing—a fear-like behavior in this
406test—was reduced by FAAH inhibition (F treatment (1, 12)=
4075.32; p<0.05) (Fig. 2c). Interestingly, the direction of explora-
408tion was also changed. Particularly, URB597-treated mice in-
409creased the exploration of the space between and beneath the
410metallic grid by which shocks were delivered (F treatment (1, 12)=
4114.77; p<0.05) (Fig. 2d). Exploration directed towards the air
412(“upward search”) was not affected (data not shown).
413Taken together, these findings show that electric shocks
414markedly reduced behavioral activity, and URB597 amelio-
415rated this behavioral inhibition.
416Sleep in response to shocks and reminder
417Sleep amount and sleep fragmentation were presented in
418Tables 1 and 2, respectively. The most interesting differences
419occurred between the shock day and the reminder. Figure 3
420was compiled to clearly show these differences. Noteworthy,
421statistics was done on the raw data. Figure 3 was presented for
422clarity only.
423Sleep amount was affected by an interaction between the
424condition (treatment administered before shocks and the situ-
425ation, i.e., shock or reminder) and the time elapsed from
426exposure to shocks or reminder (F condition*time (21, 168)=
4271.98; p <0.01). Surprisingly, the impact of shocks on sleep
428amount was not particularly strong. During the 30 min that
429followed shock exposure, 20–30 % of time was already spent
430sleeping, and pre-shock levels of 80 % were resumed within
431about 90 min. This was true for both vehicle- and URB597-
432treated mice (Table 1). In contrast, sleep was considerably
433more reduced in control mice after the contextual reminder,
434although no shocks were delivered this time (Table 1 and
435Fig. 3a). At the end of the investigation period, control mice
436slept significantly more after the reminder than after the shock,
437a possible rebound effect. No similar changes were noticed in
438the URB597 group, where sleep amount was similar after
439shocks and reminder (Table 1; Fig. 3b).
440Shock exposure resulted in fragmented sleep that was
441affected by an interaction between condition and time after
442shock or reminder (F condition*time (21, 112)=2.03; p =0.0097).
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Fig. 1 The impact of URB597 on behavior shown in the back test. Note
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Correlation between behaviors shown during the second and third trial,
when both were preceded by vehicle treatment; b correlation between
behaviors in mice which received URB597 before the third trial; c coping
style-dependent duration of escape attempts in mice treated with vehicle
two times; d coping style-dependent duration of escape attempts in mice
treated with URB597 before the third trial. Asterisk significant effect of
URB597 on the duration of escape attempts in passive copers (p=0.02)
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443 The period of fragmented sleep covered the whole post-shock
444 period albeit its magnitude was gradually reduced (Table 2).
445 Surprisingly, the contextual reminder administered 14 days
446 later increased sleep fragmentation immediately following the
447 reminder as compared to the same period that followed shock
448 exposure (Table 2; Fig. 3c). In contrast, mice submitted to
449 shocks concurrently with FAAH inhibition did not show this
450 increment in sleep fragmentation when exposed to the remind-
451 er. Moreover, sleep fragmentation after the reminder was
452 ameliorated in this group as compared to the shock condition
453 (Table 2; Fig. 3d).
454 Taken together, the findings suggest that the URB597-
455 induced increase in active coping with shocks had a long-
456 term emotional impact as shown by the sleep patterns.
457 Freezing during the contextual reminder and correlations
458 Mice readily showed freezing when re-exposed to the cage
459 where they received electric shocks earlier (Fig. 3e). This be-
460 havior was marginally affected by URB597 treatments received
461 before shock application, i.e., 14 days earlier (F (1, 11)=3.37;
462 0.1>p >0.05). The marginally significant difference and the
463 distribution of individual freezing score suggest that freezing
464may have been decreased in some mice, but this was not a
465general phenomenon. The correlation between freezing scores
466shown during and sleep variables shown immediately after
467shocks and reminder (first 30 min after the events) was not
468significant (sleep amount : R=0.257; p=0.18; sleep fragmenta-
469tion: R=−0.014; p=0.95). In contrast, sleep amount and sleep
470fragmentation showed a strong negative correlation (R=−0.782;
471p=0.00005). This suggests that behavior shown during expo-
472sure is not significantly correlated with sleep patterns that follow
473exposure. Thus, the immediate response to the stressful event
474and its subsequent emotional impact are independent measures.
475Discussion
476Main findings
477Overall, the behavior of mice was dominated by escape at-
478tempts in the back test, i.e., by an active coping strategy.
479However, large inter-individual variation was noticed, which
480allowed the identification of coping styles. As expected, these
481strategies were stable over time. Foot-shocks dramatically
482reduced behavioral activity in all undrugged mice, indicating
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t1:1 Table 1 Sleep amount after shocks and reminder in mice treated with vehicle and URB597 before shocks
t1:2 Group Period BL 0–30 30–60 60–90 90–120 120–150 150–180 180–210
t1:3 Vehicle Shock 73.47±5.51 31.67±6.72 59.74±4.56 72.40±5.72 72.30±7.68 76.03±4.65 82.14±7.30 77.71±4.88
t1:4 Reminder 77.90±7.11 2.47±1.56 38.57±9.10 60.39±6.78 76.03±5.56 85.80±3.74 91.20±3.45 92.54±1.97
t1:5 URB597 Shock 76.14±3.49 20.71±9.02 57.39±2.71 70.71±3.91 69.69±5.33 79.86±5.16 72.53±6.95 81.03±4.52
t1:6 Reminder 83.97±4.57 13.66±7.83 36.17±10.98 67.14±11.59 79.11±5.96 86.26±6.08 84.13±6.70 74.34±8.73
Figures in column headings indicate the starting and ending points of the periods analyzed (min). For ANOVA analysis, see text; for pairwise
comparisons, see Fig. 3a, b
BL baseline
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483 that they adopted a passive coping strategy when faced with
484 this strong challenge. URB597 promoted active challenge
485 responding in both tests. In the back test, this effect was
486 restricted to mice characterized by a passive coping style.
487 During foot-shocks, URB597 considerably ameliorated
488shock-induced behavioral passivity in all mice. Interestingly,
489behavioral activation was paralleled by increased grid search.
490Albeit findings related to the direction of exploration are
491difficult to interpret, an increased grid search suggests either
492a search for escape routes or an attempt to identify the source
493of the pain. As such, this behavior may reflect a more
494problem-oriented behavior. In line with earlier findings (Jha
495et al. 2005; Sanford et al. 2003), both shock exposure and the
496reminder were followed by a period of reduced and
497fragmented sleep. Surprisingly, larger sleep disturbances were
498noticed after the reminder than after shocks. URB597 admin-
499istered before shocks had minor effects on shock-induced
500sleep deficits but abolished the increment of such deficits after
501the reminder.
502Taken together, these findings show that URB597 promot-
503ed active coping when mice were exposed to challenging
504situations; moreover, active coping shown during challenge
505exposure reduced the long-term emotional impact of the
506challenge.
507Earlier studies suggested that the impact of URB597 on be-
508havioral responses triggered by environmental adversity is medi-
509ated by theCB1 receptor (Haller et al. 2009).Nevertheless, certain
510effects of endocannabinoids are mediated by receptors other than
511the CB1, e.g., by the vanilloid receptor type-1 and the poorly
512known cannabinoid receptor type-3 and receptors (Almeida-
513Santos et al. 2013; Hajos et al. 2001; Haller et al. 2002;
514Marinelli et al. 2007; Ryberg et al. 2007). In addition, URB597
515blocks the degradation of several lipid mediators, e.g., ananda-
516mide, oleoylethanolamide, and palmitoylethanolamide (Fegley
517et al. 2005; Piomelli et al. 2006), and the latter two may exert
518their effects via peroxisome proliferator-activated receptor alpha
519(Mazzola et al. 2009). Therefore, the mechanisms by which
520URB597 affects stress coping need further studies.
521Comparison with earlier findings
522The role of endocannabinoids in stress coping was recently
523substantiated by several studies, e.g., it was shown that striatal
524anandamide participates in the emotional arousal resulting
525from a non-familiar social encounter (Trezza et al. 2012;
t2:1 Table 2 The impact of URB597 administered before shocks on the number of awakenings per minute of sleep following shock exposure and the
contextual reminder
t2:2 Group Period BL 0–30 30–60 60–90 90–120 120–150 150–180 180–210
t2:3 Vehicle Shock 0.20±0.02 1.40±0.39 1.27±0.24 0.99±0.19 0.71±0.23 0.60±0.19 0.41±0.12 0.44±0.08
t2:4 Reminder 0.12±0.02 3.75±1.18 1.56±0.32 1.00±0.25 0.59±0.12 0.36±0.09 0.24±0.07 0.19±0.04
t2:5 URB597 Shock 0.18±0.01 2.30±0.54 1.20±0.11 0.89±0.10 0.82±0.13 0.62±0.06 0.64±0.11 0.52±0.07
t2:6 Reminder 0.11±0.03 2.28±1.12 1.06±0.20 0.89±0.34 0.36±0.13 0.22±0.05 0.22±0.05 0.21±0.04
Boundaries in column headings indicate the starting and ending points of the periods analyzed; values represent minutes elapsed from the shock or the
reminder. For ANOVA analysis, see text; for pairwise comparisons, see Fig. 3c, d
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Fig. 3 The effects of URB597 on sleep following shocks and contextual
reminders. Data show differences between the shock day and the reminder.
The compound was administered before shocks only. For raw data, see
Tables 1 and 2. a Sleep amount in mice treated with vehicle before shocks;
b sleep amount in mice treated with URB597 before shocks; c fragmented
sleep (awakenings/minute of sleep) in mice treated with vehicle before
shocks; d fragmented sleep (awakenings/minute of sleep) in mice treated
withURB597 before shocks; e the duration of freezing during the reminder
(individual values were shown). Thick horizontal gray lines indicate the
reference values of the shock day; thin vertical gray lines indicate the
standard error of reference values. BL baseline, number symbol significant
difference between shock and reminder (p>0.05)
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526 Gururajan et al. 2012) and is particularly important for coping
527 responses to novel social contexts in terms of the time spent with
528 social investigation (Marco et al. 2011). It was also shown that
529 FAAH inhibition promotes active responses (e.g., swimming)
530 and inhibits passive responses (e.g., immobility) in the forced
531 swimming test (McLaughlin et al. 2012; Realini et al. 2011).
532 Cognitive flexibility—an important characteristic of coping
533 styles (Koolhaas et al. 1999, 2007)—was markedly inhibited
534 by URB597 in another study (Sokolic et al. 2011). Direct effects
535 on cannabinoid receptors—e.g., Δ9-tetrahydrocannabinol treat-
536 ments—also facilitated a switch from passive to active behavior
537 in fear conditioning (Metna-Laurent et al. 2012).
538 Taken together, these findings substantiate the view that the
539 endocannabinoid anandamide has an important role in coping
540 with challenges. Particularly, anandamide signaling appears to
541 promote active coping. This conclusion was supported here by
542 studies involving two tests that pose challenges of different
543 intensities. A coping strategy-dependent effect was noticed in
544 the back test, which did not seem to be particularly challenging
545 for mice. A more general effect was seen during foot-shocks, a
546 very strong stressor that washed out differences between base-
547 line coping styles.
548 We believe that the most interesting finding of this study is
549 that active coping with a dramatic stressor has long-term con-
550 sequences for the emotional impact of contextual reminders. It
551 is highly unlikely that the pharmacological effects of a single
552 URB597 treatment lasted 14 days (Piomelli et al. 2006).
553 Nevertheless, active coping with a critical situation—prompted
554 here by URB597—may have affected “subjective” feelings
555 associated with that particular event, which may have amelio-
556 rated emotional responses elicited by its re-experiencing.
557 Theoretical implications
558 Although data point to the involvement of endocannabinoid
559 signaling in the control of emotional behavior, the pharmacolog-
560 ical evidence seems rather inconsistent (see, for reviews, Viveros
561 et al. 2005;Witkin et al. 2005; Zanettini et al. 2011). One possible
562 reason for such discrepancies is the role of cannabinoid signaling
563 in coping with environmental adversity as shown here and in a
564 number of recent publications (Haller et al. 2009, 2013; Marco
565 et al. 2011; McLaughlin et al. 2012; Metna-Laurent et al. 2012;
566 Naidu et al. 2007; Realini et al. 2011; Sciolino et al. 2011). Taken
567 together, these publications suggest that endocannabinoid signal-
568 ing decreases the emotional impact of aversive conditions and
569 promotes active coping with adversities. In addition to anxiety-
570 and depression-like behaviors, the effects of endocannabinoid
571 signaling on learning may also be affected by this mechanism as
572 the learning-related effects of endocannabinoid signaling also
573 depend on the aversiveness of testing conditions (Abush and
574 Akirav 2010; Campolongo et al. 2012, 2013). Taken together,
575 these findings suggest that studying the effects of cannabinoids in
576 conjunction with environmental conditions is a promising
577approach and may lead to a better understanding of the roles
578played by endocannabinoids in behavior. On a more general
579level, these findings—if supported by subsequent studies—
580may open new therapeutic windows for agents that increase
581endocannabinoid signaling. Active coping is a therapeutic goal
582in a variety of physical and mental diseases (Cooke et al. 2007;
583Westerhuis et al. 2011). Potentially, such goals may be achieved
584by enhancing anandamide signaling.
585Conclusions
586In behavioral terms, URB597 promoted active coping with
587two stressful situations, namely, a forced unnatural position
588and foot-shocks. The URB597-induced increase in active
589coping reduced the long-term emotional impact of contextual
590reminders. Taken together, these findings suggest that
591endocannabinoid signaling has an important role in the selec-
592tion of behavioral responses under challenging conditions
593and—judging from its long-term effects—that it influences
594the cognitive appraisal of the challenge. These findings war-
595rant further studies into the role of endocannabinoids in cop-
596ing with challenges.
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